Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 6,000.00
+30.00 (0.50%)
Last updated: Sep 19, 2025, 9:31 AM KST
Pharos iBio Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
33
Market Cap
75.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 300.00M | 243.00M | 426.32% |
| Dec 31, 2021 | 57.00M | -130.68M | -69.63% |
| Dec 31, 2020 | 187.68M | -233.43M | -55.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |